Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review

Date: July 5, 2017
Pages: 32
Price:
US$ 125.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A34065A0D30EN
Leaflet:

Download PDF Leaflet

Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review
Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description – A detailed description of the company’s operations and business divisions.
  • Corporate strategy – Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history – Progression of key events associated with the company.
  • Major products and services – A list of major products, services and brands of the company.
  • Key competitors – A list of key competitors to the company.
  • Key employees – A list of the key executives of the company.
  • Executive biographies – A brief summary of the executives’ employment history.
  • Key operational heads – A list of personnel heading key departments/functions.
  • Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities – A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Amarillo Biosciences Inc (ABI) is a specialty biopharmaceutical company, which focuses on the development of biologics for the treatment of human and animal diseases. It develops innovative therapeutic candidates for the treatment of human disease indications such as influenza, hepatitis C, thrombocytopenia, and other indications using natural human interferon alpha. Its product portfolio includes a dietary supplement product, Maxisal to treat dryness of mouth. The company utilizes injectable interferon, an FDA-approved technology to develop drugs for the treatment of neoplastic, viral and autoimmune diseases. It has development partners in China and Taiwan and Nepal. ABI is headquartered in Amarillo, Texas, the US.

Amarillo Biosciences Inc Key Recent Developments

Oct 06,2016: Amarillo Biosciences Receives Approval of Patent Claims - Treatment of Thrombocytopenia Using Orally Administered Interferon

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
SECTION 1 - ABOUT THE COMPANY

Amarillo Biosciences Inc - Key Facts
Amarillo Biosciences Inc - Key Employees
Amarillo Biosciences Inc - Key Employee Biographies
Amarillo Biosciences Inc - Major Products and Services
Amarillo Biosciences Inc - History
Amarillo Biosciences Inc - Locations And Subsidiaries
Head Office

SECTION 2 – COMPANY ANALYSIS

Amarillo Biosciences Inc - Business Description
Amarillo Biosciences Inc - SWOT Analysis
SWOT Analysis - Overview
Amarillo Biosciences Inc - Strengths
Amarillo Biosciences Inc - Weaknesses
Amarillo Biosciences Inc - Opportunities
Amarillo Biosciences Inc - Threats
Amarillo Biosciences Inc - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Amarillo Biosciences Inc, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Oct 06, 2016: Amarillo Biosciences Receives Approval of Patent Claims - Treatment of Thrombocytopenia Using Orally Administered Interferon

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

Amarillo Biosciences Inc, Key Facts
Amarillo Biosciences Inc, Key Employees
Amarillo Biosciences Inc, Key Employee Biographies
Amarillo Biosciences Inc, Major Products and Services
Amarillo Biosciences Inc, History
Amarillo Biosciences Inc, Key Competitors
Amarillo Biosciences Inc, Ratios based on current share price
Amarillo Biosciences Inc, Annual Ratios
Amarillo Biosciences Inc, Annual Ratios (Cont.1)
Amarillo Biosciences Inc, Interim Ratios
Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017
Amarillo Biosciences Inc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

LIST OF FIGURES

Amarillo Biosciences Inc, Performance Chart (2012 - 2016)
Amarillo Biosciences Inc, Ratio Charts
Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017
Amarillo Biosciences Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017

COMPANIES MENTIONED

InterMune Inc
Hoffmann-La Roche Inc
Hemispherx Biopharma Inc
Skip to top


Ask Your Question

Amarillo Biosciences Inc (AMAR) - Financial and Strategic SWOT Analysis Review
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: